US$ 22.71
glp-1 and gip dual agonist GLP-1/GIP | Tirzepatide | Obesity & T2DM Mx | Harrison's Update(22nd Ed.) Major physiological roles of GLP-1
Description
[DOI] [PubMed] [Google Scholar] 132.Sumithran P., Russell A.W., Zoungas S
Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes and obesity: a systematic review and meta-analysis

Cost effectiveness and equitable access will need careful consideration if GLP-1RAs are to be deployed more broadly in NDDs

Y., Fu, S

Ethics declarations Ethical approval and consent to participate Not applicable

Lancet 2019;394:121130 [DOI] [PubMed] [Google Scholar] 27.Hernandez AF, Green JB, Janmohamed S, et al
